Empr.com View all drugs

Prescription & OTC Drug Info Side Effects, Interactions

Details: MPR provides drug monographs, drug news and e-prescribing service for healthcare professionals. We provides drug dosing, interactions, recalls and more for medical professionals.

› Verified 1 days ago

› Url: https://www.empr.com/ Go Now

› Get more:  MedicalGo Now

Drug Database for Healthcare Practitioners Drug Dosing

Details: The MPR Drug Reference Database for Healthcare Practitioners. Our drug database contains more than 4,000 concise product monographs (for both over the counter (OTC) and prescription drugs). Each

› Verified 5 days ago

› Url: https://www.empr.com/drug-database/ Go Now

› Get more:  DoctorGo Now

Browse by Drug Brands

Details: Drugs A-AC. Drug Name. A AND D OINTMENT. Diaper rash. A AND D WITH ZINC OXIDE. Diaper rash. ABECMA. Leukemias, lymphomas, and other hematologic cancers. ABELCET.

› Verified 5 days ago

› Url: https://www.empr.com/drug/letter/a/ Go Now

› Get more:  CancerGo Now

TRULICITY Dosage & Rx Info Uses, Side Effects

Details: TRULICITY prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.

› Verified 6 days ago

› Url: https://www.empr.com/drug/trulicity/ Go Now

› Get more:  DoctorGo Now

MONOVISC Dosage & Rx Info Uses, Side Effects

Details: MONOVISC prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.

› Verified 5 days ago

› Url: https://www.empr.com/drug/monovisc/ Go Now

› Get more:  DoctorGo Now

AMBIEN Dosage & Rx Info Uses, Side Effects

Details: AMBIEN prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.

› Verified 3 days ago

› Url: https://www.empr.com/drug/ambien/ Go Now

› Get more:  DoctorGo Now

TAGAMET Dosage & Rx Info Uses, Side Effects

Details: TAGAMET prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.

› Verified 4 days ago

› Url: https://www.empr.com/drug/tagamet/ Go Now

› Get more:  DoctorGo Now

REPLENS Dosage & Rx Info Uses, Side Effects

Details: REPLENS prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.

› Verified 4 days ago

› Url: https://www.empr.com/drug/replens/ Go Now

› Get more:  DoctorGo Now

Concordia Pharmaceuticals Inc.

Details: Drugs Open Submenu. Drugs Back. Drug Search . Browse by Brand; Browse by Generic; Browse by Therapeutic Category; Browse by Manufacturer; More . New …

› Verified 3 days ago

› Url: https://www.empr.com/manufacture/concordia-pharmaceuticals-inc/ Go Now

› Get more:  DoctorGo Now

Emergency Use Request Submitted for Molnupiravir for Mild

Details: Merck and Ridgeback Biotherapeutics have submitted a request to the Food and Drug Administration (FDA) for Emergency Use Authorization for molnupiravir, an investigational oral antiviral for the

› Verified 2 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/emergency-use-request-submitted-for-molnupiravir-for-mild-to-moderate-covid-19/ Go Now

› Get more:  DoctorGo Now

Eisai Begins Rolling BLA Submission of Lecanemab for Early

Details: Credit: Getty Images . Eisai has initiated a rolling submission to the Food and Drug Administration for its Biologics License Application for lecanemab (BAN2401), an investigational anti-amyloid

› Verified Just Now

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/eisai-begins-rolling-bla-submission-of-lecanemab-for-early-alzheimer-disease/ Go Now

› Get more:  DoctorGo Now

Trehalose Fast Tracked for Spinocerebellar Ataxia

Details: The Food and Drug Administration (FDA) has accepted the Investigational New Drug Application and granted Fast Track designation to SLS-005 (trehalose) for the treatment of spinocerebellar ataxia

› Verified 3 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/trehalose-fast-tracked-for-spinocerebellar-ataxia/ Go Now

› Get more:  DoctorGo Now

Abbott Laboratories

Details: Abbott Laboratories. 100 Abbott Park Rd. Abbott Park, IL 60064-3500. Tel: (847) 937-6100.

› Verified 3 days ago

› Url: https://www.empr.com/manufacture/abbott-laboratories/ Go Now

› Get more:  DoctorGo Now

Novel CRISPR Therapy Gets Orphan Drug Status for

Details: Novel CRISPR Therapy Gets Orphan Drug Status for Transthyretin Amyloidosis. Using CRISPR/Cas9 technology, the investigational therapy is designed to edit disease-causing genes inside the human

› Verified 8 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/novel-crispr-therapy-gets-orphan-drug-status-for-transthyretin-amyloidosis/ Go Now

› Get more:  DoctorGo Now

Drugs Contraindicated in Pregnancy

Details: A list of drugs that are contraindicated for women who are pregnant (Pregnancy Category X). Drugs that are contraindicated at a certain phase of the pregnancy are indicated next to the product name.

› Verified 7 days ago

› Url: https://www.empr.com/home/clinical-charts/drugs-contraindicated-in-pregnancy/ Go Now

› Get more:  DoctorGo Now

Tezepelumab Granted Orphan Drug Status for Eosinophilic

Details: The Food and Drug Administration (FDA) has granted Orphan Drug designation to tezepelumab for the treatment of eosinophilic esophagitis. Tezepelumab is an investigational first-in-class human

› Verified 1 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/tezepelumab-granted-orphan-drug-status-for-eosinophilic-esophagitis/ Go Now

› Get more:  DoctorGo Now

Rhodes Pharmaceuticals

Details: Drugs Open Submenu. Drugs Back. Drug Search . Browse by Brand; Browse by Generic; Browse by Therapeutic Category; Browse by Manufacturer; More . New …

› Verified 6 days ago

› Url: https://www.empr.com/manufacture/rhodes-pharmaceuticals/ Go Now

› Get more:  DoctorGo Now

Browse Drugs By Manufacturers

Details: Drugs Open Submenu. Drugs Back. Drug Search . Browse by Brand; Browse by Generic; Browse by Therapeutic Category; Browse by Manufacturer; More . New …

› Verified 4 days ago

› Url: https://www.empr.com/manufactures/ Go Now

› Get more:  DoctorGo Now

Bimekizumab Significantly Improves Joint, Skin Symptoms in

Details: Bimekizumab is an investigational humanized monoclonal IgG1 antibody that selectively inhibits both interleukin (IL)-17A and IL-17F. The randomized, double-blind, placebo-controlled

› Verified 7 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/bimekizumab-significantly-improves-joint-skin-symptoms-in-psoriatic-arthritis-trial/ Go Now

› Get more:  DoctorGo Now

Posoleucel Gets Orphan Drug Status for Virus-Associated

Details: Posoleucel Gets Orphan Drug Status for Virus-Associated Hemorrhagic Cystitis. Posoleucel is an investigational, allogeneic, off-the-shelf, multi-virus specific T-cell therapy. Credit: Getty Images

› Verified Just Now

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/posoleucel-gets-orphan-drug-status-for-virus-associated-hemorrhagic-cystitis/ Go Now

› Get more:  DoctorGo Now

AstraZeneca Seeks EUA for Long-Acting Antibody Combo for

Details: AstraZeneca is seeking Emergency Use Authorization (EUA) for AZD7442, a combination of 2 long-acting monoclonal antibodies for prophylaxis of symptomatic COVID-19. The investigational antibodies

› Verified Just Now

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/astrazeneca-seeks-eua-for-long-acting-antibody-combo-for-covid-19-prevention/ Go Now

› Get more:  DoctorGo Now

Gene Therapy Candidate Designated Orphan Drug for Buerger

Details: Gene Therapy Candidate Designated Orphan Drug for Buerger Disease. AMB-301 is a first-in-class gene therapy candidate that uses an AAV vector to deliver E-selectin to damaged blood vessels. Credit

› Verified 9 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/gene-therapy-candidate-designated-orphan-drug-for-buerger-disease/ Go Now

› Get more:  DoctorGo Now

Review: Medications Linked to Hyperlactatemia, Lactic

Details: Review: Medications Linked to Hyperlactatemia, Lactic Acidosis. Medications may cause elevated lactate levels which could potentially lead to hyperlactatemia and lactic acidosis, according to a

› Verified 2 days ago

› Url: https://www.empr.com/home/news/review-medications-linked-to-hyperlactatemia-lactic-acidosis/ Go Now

› Get more:  DoctorGo Now

DRUGS CONTRAINDICATED IN PREGNANCY (Part 1 of 3)

Details: DRUGS CONTRAINDICATED IN PREGNANCY (Part 2 of 3) OB/GYN (continued) methylergonovine Methergine All mifepristone Mifeprex All nafarelin acetate Synarel All …

› Verified 1 days ago

› Url: https://www.empr.com/wp-content/uploads/sites/7/2021/10/Drugs-Contraindicated-in-Pregnancy-0921-1.pdf Go Now

› Get more:  DoctorGo Now

Flare Risk Reduced With Secukinumab in 2 Types of Juvenile

Details: Findings showed that treatment with secukinumab resulted in a significantly longer time to flare with a 72% reduction in the risk of flare at week 104 compared with placebo ( P <.001

› Verified 3 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/flare-risk-reduced-with-secukinumab-in-2-types-of-juvenile-idiopathic-arthritis/ Go Now

› Get more:  DoctorGo Now

FDA Committee Supports Janssen COVID-19 Vaccine Booster

Details: An FDA panel voted unanimously to amend the EUA for the Janssen COVID-19 vaccine to include use of a booster dose in individuals 18 years of age and older at least 2 months after a single dose

› Verified 9 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-committee-supports-janssen-covid-19-vaccine-booster/ Go Now

› Get more:  DoctorGo Now

DRUGS CONTRAINDICATED IN PREGNANCY (part 1 of 2)

Details: DRUGS CONTRAINDICATED IN PREGNANCY (part 2 of 2) Not an inclusive list. (Rev. 10/2012) Bexxar (tositumomab) Casodex (bicalutamide) Delestrogen (estradiol valerate) Efudex (fluorouracil) Eligard (leuprolide acetate) Estrace (estradiol) Evista (raloxifene HCl) Firmagon (degarelix) Fluoxymesterone Menest (esterified estrogens) Revlimid (lenalidomide)

› Verified 7 days ago

› Url: http://media.empr.com/documents/2/obgyn-dcip_2pt_1170.pdf Go Now

› Get more:  DoctorGo Now

Travel Restrictions Hinder Bimekizumab BLA Review

Details: The Food and Drug Administration (FDA) is deferring action on the Biologics License Application (BLA) for bimekizumab for the treatment of moderate to severe plaque psoriasis due to COVID-19

› Verified 3 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/travel-restrictions-hinder-bimekizumab-bla-review/ Go Now

› Get more:  DoctorGo Now

Ublituximab BLA Submitted for Relapsing Forms of Multiple

Details: A Biologics License Application has been submitted to the Food and Drug Administration (FDA) for ublituximab for the treatment of patients with relapsing forms of multiple sclerosis.

› Verified 1 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/ublituximab-bla-submitted-for-relapsing-forms-of-multiple-sclerosis/ Go Now

› Get more:  DoctorGo Now

Drug-Induced Photosensitivity

Details: 1 Drugs that have been reported in medical literature to cause clinical photosensitivity are listed. Most of this literature consist of case reports and case series. Due to underreporting, it is

› Verified 2 days ago

› Url: https://www.empr.com/home/clinical-charts/drug-induced-photosensitivity/ Go Now

› Get more:  MedicalGo Now

Durable Improvements Observed With Long-Term Guselkumab in

Details: Durable Improvements Observed With Long-Term Guselkumab in Psoriatic Arthritis Trial. Brian Park, PharmD. Tremfya (guselkumab) is a selective IL-23 inhibitor. Credit: Getty Images . Positive

› Verified 8 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/durable-improvements-observed-with-long-term-guselkumab-in-psoriatic-arthritis-trial/ Go Now

› Get more:  DoctorGo Now

ANTIRETROVIRAL CONTRAINDICATIONS AND DRUG …

Details: † Monitor drugs that reduce renal function or compete for renal tubular secretion (eg, adefovir dipivoxil, cidofovir, acyclovir, valacyclovir, ganciclovir, valganciclovir). † Avoid concomitant or recent use of nephrotoxic agents. † Potentiated by lopinavir/ritonavir, atazanavir; monitor for toxicity.

› Verified 3 days ago

› Url: http://media.empr.com/documents/11/hiv-arvc_di_5pt2123_2735.pdf Go Now

› Get more:  DoctorGo Now

FDA Panel Votes on Maribavir for Post-Transplant CMV

Details: The Food and Drug Administration (FDA)’s Antimicrobial Drugs Advisory Committee voted unanimously to recommend the use of maribavir for the treatment of refractory cytomegalovirus (CMV

› Verified 6 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-panel-votes-on-maribavir-for-post-transplant-cmv-infection/ Go Now

› Get more:  DoctorGo Now

Viloxazine Under Review for ADHD Treatment in Adults

Details: A Prescription Drug User Fee Act (PDUFA) target date of April 29, 2022 has been set for the application. Viloxazine is currently marketed under the trade name Qelbree and is indicated for the

› Verified 6 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/viloxazine-under-review-for-adhd-treatment-in-adults/ Go Now

› Get more:  DoctorGo Now

The Role of Generic Drugs in Patient Care and the

Details: brand-name drugs. To be approved by the FDA, manufacturers have to show that the generic drug works the same way in the body as the brand-name drug. This is known as bioequivalence.1 Myth: Generic drugs look and act differently than the brand-name drugs. Fact: Generic drugs look different because certain inactive ingredients,

› Verified 5 days ago

› Url: http://media.empr.com/documents/90/the_impact_of_generics_drugs_i_22399.pdf Go Now

› Get more:  DoctorGo Now

Bausch Health Companies Inc.

Details: Drugs Open Submenu. Drugs Back. Drug Search . Browse by Brand; Browse by Generic; Browse by Therapeutic Category; Browse by Manufacturer; More . New …

› Verified 1 days ago

› Url: https://www.empr.com/manufacture/bausch-health-companies-inc/ Go Now

› Get more:  DoctorGo Now

Alvelestat Designated Orphan Drug for Alpha-1 Antitrypsin

Details: Credit: Getty Images . The Food and Drug Administration (FDA) has granted Orphan Drug designation to alvelestat (MPH-966) for the treatment of alpha-1 antitrypsin deficiency (AATD). AATD is a rare

› Verified 2 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/alvelestat-designated-orphan-drug-for-alpha-1-antitrypsin-deficiency/ Go Now

› Get more:  DoctorGo Now

Response to Pegloticase Therapy Improved With Concomitant

Details: Results from the open-label MIRROR trial (ClinicalTrials.gov Identifier: NCT03635957) showed a response rate (sUA less than 6mg/dL) of 79% (n=11/14 patients) at month 6 …

› Verified 4 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/response-to-pegloticase-therapy-improved-with-concomitant-methotrexate/ Go Now

› Get more:  DoctorGo Now

Study Shows Similar Safety Profile With Rivaroxaban vs ASA

Details: Study Shows Similar Safety Profile With Rivaroxaban vs ASA After Fontan Procedure. Brian Park, PharmD. Rivaroxaban is a Factor Xa inhibitor. Credit: Getty Images . New data were announced from a

› Verified 5 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/study-shows-similar-safety-profile-with-rivaroxaban-vs-asa-after-fontan-procedure/ Go Now

› Get more:  DoctorGo Now

Intranasal Nalmefene Fast Tracked for Opioid Overdose

Details: The Food and Drug Administration (FDA) has granted Fast Track designation to OPNT003 (nasal nalmefene) for the treatment of opioid overdose. OPNT003 is being developed as an alternative to

› Verified 7 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/intranasal-nalmefene-fast-tracked-for-opioid-overdose-treatment/ Go Now

› Get more:  DoctorGo Now

OB/GYN News & Articles Obstetrics, Gynecology Resource

Details: Drugs in the Pipeline. Linzagolix NDA Submitted for Uterine Fibroid Treatment By Brian Park, PharmD. Publish Date September 15, 2021 Drugs in the Pipeline. FDA to Review Relugolix Combination

› Verified Just Now

› Url: https://www.empr.com/home/resource-centers/ob-gyn/ Go Now

› Get more:  DoctorGo Now

Gantenerumab Designated Breakthrough Therapy for Alzheimer

Details: The Food and Drug Administration has granted Breakthrough Therapy designation to gantenerumab for the treatment of Alzheimer disease. Gantenerumab is an investigational immunoglobulin G1 antibody

› Verified Just Now

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/gantenerumab-designated-breakthrough-therapy-for-alzheimer-disease/ Go Now

› Get more:  DoctorGo Now

FDA Panel Votes in Favor of Pfizer-BioNTech COVID-19

Details: The FDA’s Vaccines and Related Biological Products Advisory Committee voted in favor (17 yes with 1 abstention) of amending the EUA for the Pfizer-BioNTech COVID-19 vaccine to include use in

› Verified 6 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-panel-votes-in-favor-of-pfizer-biontech-covid-19-vaccine-for-5-to-11-year-olds/ Go Now

› Get more:  DoctorGo Now

Bamlanivimab Plus Etesevimab Authorized for Postexposure

Details: Bamlanivimab plus etesevimab continues to be authorized for the treatment of mild to moderate COVID-19 in patients 12 years of age and older weighing at least 40kg who test positive for SARS-CoV-2

› Verified 5 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/bamlanivimab-plus-etesevimab-authorized-for-postexposure-prophylaxis-for-covid-19/ Go Now

› Get more:  DoctorGo Now

Tyvaso DPI Approval Decision Delayed Over Inspection Issue

Details: Tyvaso DPI is an investigational drug-device combination therapy that consists of a dry powder formulation of treprostinil and a small, portable, dry powder inhaler. In the CRL, the Agency cited a

› Verified 2 days ago

› Url: https://www.empr.com/home/news/drugs-in-the-pipeline/tyvaso-dpi-approval-decision-delayed-over-inspection-issue/ Go Now

› Get more:  DoctorGo Now

Related topics